| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| LHF-535 | LHF-535; LHF-535-SDD | Phase 1 Clinical | Kineta Inc | Details | |
| SAR-440894 | SAR-440894 | Phase 1 Clinical | National Institute Of Allergy And Infectious Diseases (Niaid) | Chikungunya Fever | Details |